Clinical Trial Update: Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers [Phase 4]

View source ↗

Summary

This Phase 4 study investigates whether morning versus evening dosing of endocrine-based therapies improves outcomes in metastatic breast cancer and metastatic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Prostate Cancer

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Metastatic Breast Cancer, Metastatic Prostate Cancer | Phase 4 | Status: RECRUITING